Douglas J. O'Dowd
Director Financiero/CFO en Xcelience LLC .
Origen de la red de primer grado Douglas J. O'Dowd.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Xcelience LLC
 Xcelience LLC Pharmaceuticals: MajorHealth Technology Xcelience LLC provides drug development and manufacturing solutions. Its services include preformulation, analytical development services, release and stability testing, formulation development, gmp manufacturing, small-scale commercial manufacturing and global clinical supplies packaging. The company was founded by Derek G. Hennecke in 2006 and is headquartered in Tampa, FL.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Douglas J. O'Dowd a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Colorado State University | College/University | Undergraduate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DSM Life Sciences Products | Corporate Officer/Principal | ||
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The American Academy of Political & Social Science | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Países Bajos | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Operativa
| Corporate Officer/Principal | 7 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Chief Operating Officer | 1 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Douglas J. O'Dowd
- Conexiones Empresas
